Abivax Stock (NASDAQ: ABVX) stock price, news, charts, stock research, profile.
Open | $13.56 |
Close | - |
Volume / Avg. | 22.42K / 51.59K |
Day Range | 13.13 - 13.73 |
52 Wk Range | 8.00 - 17.02 |
Market Cap | $853.79M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | - |
Days to Cover | 1.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Abivax (NASDAQ:ABVX) through any online brokerage.
Other companies in Abivax’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE) and CareDx (NASDAQ:CDNA).
There is no analysis for Abivax.
Abivax has a consensus price target of $34.20.
The stock price for Abivax (NASDAQ: ABVX) is $13.2 last updated Today at July 17, 2024 at 1:59 PM EDT.
There are no upcoming dividends for Abivax.
Abivax’s H1 earnings are confirmed for Monday, September 9, 2024.
There is no upcoming split for Abivax.
Abivax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.